Mundipharma in the news
Global healthcare products distribution
Tamtam found 15 recent articles about Mundipharma.
- Mundipharma to further tap nation's health sector
Mundipharma plans to boost investment and establish local manufacturing in China, recognizing its growing role as a global medical innovation hub.
- Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients
Mundipharma reported successful Phase III clinical trial results for REZZAYO, showing it effectively prevents invasive fungal infections in stem cell transplant patients with a favorable safety profile.
- [GPTW] Mundipharma Korea head brings integrity and people-first mindset
Mundipharma Korea's leader, Daniel Cho, emphasizes integrity, employee engagement, and patient-centered values, earning him the Most Respected CEO award.
- Samjin and Mundipharma will co-supply 2 wound-care dressings to Korean hospitals
Samjin Pharmaceutical is partnering with Mundipharma to distribute Medifoam and BETAfoam wound-care dressings to secondary general hospitals in Korea.
- No damages for Glenmark in battle over Mundipharma’s Targin
Mundipharma successfully defended against Glenmark's damages claim over Targin's patent exclusivity after courts determined Mundipharma acted responsibly.
- Medical Product Alert N°1/2025: Falsified (contaminated) OXYCONTIN 80mg
A falsified batch of Oxycontin 80mg containing dangerous synthetic nitazenes was detected in Switzerland and reported by Mundipharma.
- In the US, opioid-maker Purdue is bankrupt. Its global counterparts make millions.
Mundipharma continues to generate hundreds of millions in global profits for the Sackler family by using aggressive opioid marketing tactics in international markets while their US business remains in bankruptcy.
- Revealed: How the Sackler family’s opioid empire continues to make hundreds of millions of dollars in profits around the world
Mundipharma continues to generate hundreds of millions in global profits while the Sackler family faces legal pressure to settle U.S. opioid litigation.
- Drugmaker Mundipharma's China unit sale fails to find buyer, sources say
Mundipharma has failed to sell its Chinese division for the second time after failing to reach a deal on its billion-dollar valuation.
- Mundipharma and Allen & Overy prevail after Glenmark damages claim
Mundipharma successfully defended against a lawsuit from Glenmark seeking damages for delayed generic entry after several patents were revoked.
- iNova to acquire Mundipharma’s consumer healthcare brands
iNova Pharmaceuticals is purchasing Mundipharma's consumer healthcare portfolio and Betadine brand to expand its global market presence.
- Mundipharma, Grünenthal accused of kickbacks in Italy
Mundipharma and Grünenthal face allegations of bribing an Italian doctor to promote prescription opioids and bypass government safety warnings.
- Mundipharma inks third biosimilar deal with Celltrion
Mundipharma expanded its distribution agreement with Celltrion to bring a third biosimilar cancer drug to seven European markets.
- Dentons advises Fidelio Healthcare on the acquisition of Mundipharma's production site in Limburg
Fidelio Healthcare is acquiring Mundipharma's Limburg production site to expand into contract pharmaceutical manufacturing.
- City & Mundipharma sign Betadine® partnership
Mundipharma and Manchester City have expanded their global partnership to promote Betadine through kit branding, digital presence, and youth football programs.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Mundipharma?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies